Completed NA INTERVENTIONAL 1-arm NCT02237612

Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer

Diffusion-Weighted MRI for Staging in Localized Prostate Cancer: A Pilot Study

Sponsor: National Cancer Institute (NCI)

Conditions Adenocarcinoma of the Prostate Stage IIA Prostate Cancer Stage IIB Prostate Cancer

Interventions diffusion-weighted magnetic resonance imaging laboratory biomarker analysis

Updated 5 times since 2017 Last updated: Sep 9, 2014 Started: Jan 31, 2009 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02237612, this NA trial focuses on Adenocarcinoma of the Prostate and Stage IIA Prostate Cancer and remains completed. Sponsored by National Cancer Institute (NCI), it has been updated 5 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Cancer Institute (NCI)
University of Southern California

Data source: University of Southern California

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States